Dr. Michael Choi, MD
Claim this profileUCSD Moores Cancer Center
Studies Lymphocytic Leukemia
Studies Lymphoma
5 reported clinical trials
9 drugs studied
Affiliated Hospitals
More about Michael Choi, MD
Clinical Trial Related3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Michael Choi, MD has experience with
- Ibrutinib
- Venetoclax
- BMS-986158
- Fedratinib
- Ruxolitinib
- Cirmtuzumab
Breakdown of trials Michael Choi, MD has run
Lymphocytic Leukemia
Lymphoma
Leukemia
Chronic Lymphocytic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Choi, MD specialize in?
Michael Choi, MD focuses on Lymphocytic Leukemia and Lymphoma. In particular, much of their work with Lymphocytic Leukemia has involved treating patients, or patients who are undergoing treatment.
Is Michael Choi, MD currently recruiting for clinical trials?
No, Michael Choi, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Michael Choi, MD has studied deeply?
Yes, Michael Choi, MD has studied treatments such as Ibrutinib, Venetoclax, BMS-986158.
What is the best way to schedule an appointment with Michael Choi, MD?
Apply for one of the trials that Michael Choi, MD is conducting.
What is the office address of Michael Choi, MD?
The office of Michael Choi, MD is located at: UCSD Moores Cancer Center, La Jolla, California 92093 United States. This is the address for their practice at the UCSD Moores Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.